‌

Oncology & Regenerative Medicine

This report provides industry specific statistics compiled from gene therapy, gene-modified cell therapy, cell therapy, and other regenerative medicine companies active in developing therapies to treat cancer and provides context for the potential of regenerative medicine to improve upon the current standard of care.

This report provides industry specific statistics compiled from gene therapy, gene-modified cell therapy, cell therapy, and other regenerative medicine companies active in developing therapies to treat cancer and provides context for the potential of regenerative medicine to improve upon the current standard of care.

As of June 2019:

There are 416+ companies worldwide working on regenerative medicine therapies in oncology, including 191 clinical-stage companies.

There are currently 132+ products in active development with 627 clinical trials ongoing, including 23 in Phase III.

Cancer causes one in six deaths worldwide, 18+ million people diagnosed with cancer each year and more than 9 million deaths attributed to cancer annually.

 

View Full Report

627+

Clinical trials underway
worldwide as of June 2019

PH. 1

264

PH. 2

336

PH. 3

27

42.1%53.6%0050100150200250300350Phase 1Phase 2Phase 3

Clinical Trials by Technology Type

Gene Therapy
90.0%10.0%020406080100120140Gene TransferGene Editing
Gene-Modified Cell Therapy
47.6%18.7%11.8%7.6%9.5%020406080100120140160180CAR-TTCRAPC / Dendritic CellNK CellTILs / MILsOther GMCT
Oncolytic Virus
100.0%0051015202530354045Oncolytic Virus
Cell Therapy
100.0%0051015202530354045Cell Therapy

Clinical Trials by Indication

33.5%12.3%8.0%6.2%5.3%11.6%0020406080100120140160180200220Hematological MalignanciesGastrointestinal System CancerBrain and Spinal Cord CancerSkin CancerRespiratory CancerProstate CancerGynecological CancersMultiple Solid TumorsBladder and Renal CancerBreast CancerHead and Neck CancerMultiple Cancer TypesOther or Unspecified

Companies Active in Developing Regenerative Medicines in Oncology

 

219North America82Asia104Europe & Israel1South America10Oceania

Financings

Global Financings for Regenerative Medicines in Oncology

10463082958412224923010798852344988130962167862112467117307Total FinancingsVenture FinancingPrivate Placements / PIPESIPOsCorporate Partnerships (Upfront Payments)0$500m$1,000m$1,500m$2,000m$2,500m$3,000m$3,500m$4,000m201620172018YTD 2019

Infographics

View Full Report ARM Members Active in Oncology

Alliance for Regenerative Medicine

CONTACT

1015 18th Street NW
Suite 1102
Washington, D.C. 20036

info@alliancerm.org

2-4 Schuman Roundabout
B-1040 Brussels
Belgium